imetelstat
geron corporation
['mds', 'imerge trial']
happening now, discussing results from the imerge trial showing incredible response of imelastat on transfusion independence in lr mds r/r to esa (phase 3 trial) #asco23 
PGY 2 @PittGIM丨Researcher @MDALeukemia丨MD’19 @AUB_Lebanon丨🇱🇧 🇨🇦 🇦🇪丨Opinions = Spectacular, retweet ≠ endorsement